수의 진단 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 동물별, 검사 카테고리별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Veterinary Diagnostics Market Summary

The global veterinary diagnostics market size was estimated at USD 8.4 billion in 2025 and is projected to reach USD 19.2 billion by 2033, growing at a CAGR of 11.0% from 2026 to 2033. The market is expanding steadily as pet adoption worldwide increases and owners allocate more spending toward routine veterinary examinations and preventive testing.

Routine blood work, screening panels, and early disease detection have become common components of companion animal care. In parallel, the continued occurrence of infectious and zoonotic diseases in livestock and pets is creating sustained demand for reliable diagnostic tools to support disease control, herd productivity, and food supply safety.

Moreover, the need for faster, more streamlined diagnostic processes is driving growth in the veterinary diagnostics market. In many clinics, evaluating a pet's health can take time, particularly where access to specialized clinical pathologists or parasitologists is limited. For instance, according to an article published by Zoetis in February 2026, veterinary practices in the United States collectively perform around 90 million fecal tests each year, reflecting the scale of routine diagnostic workload. Such high testing volumes are increasing interest in advanced in-clinic diagnostic systems that can shorten turnaround time, improve operational efficiency, and help veterinarians make timely treatment decisions, thereby contributing to greater adoption of modern diagnostic solutions.

Furthermore, broader adoption of structured clinical guidelines is increasing the use of detailed diagnostic workups in veterinary practice. For instance, according to an article published by AVMA, in February 2026, the American Veterinary Medical Association reported on a consensus statement from the American College of Veterinary Internal Medicine addressing chronic inflammatory enteropathy (CIE) in dogs. The document outlines a two-tier diagnostic pathway that recommends a stepwise evaluation, including detailed case history, use of standardized scoring indices such as CIBDAI and CCECAI, routine laboratory testing, imaging studies, and dietary trials before moving to invasive procedures. As clinics incorporate these recommendations into daily practice to improve case management and long-term monitoring, utilization of blood panels, fecal analysis, imaging, and related diagnostic services is likely to increase, contributing to the continued expansion of the veterinary diagnostics market.

In addition, ongoing advances in veterinary molecular testing the expanding the veterinary diagnostics market by improving the accuracy and timeliness of disease detection in both companion and production animals. Laboratory methods that analyze genetic material and protein markers are enabling veterinarians to identify infections and disorders earlier than with conventional techniques, supporting more targeted treatment decisions. For instance, in February 2026, BioVenic advanced this trend by expanding its veterinary molecular diagnostic development services, providing research teams with end-to-end technical support for new testing platforms. Efforts such as these are helping bring more precise and commercially viable molecular diagnostic tools to market, contributing to the continued growth of the sector.

Global Veterinary Diagnostics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the veterinary diagnostics market report based on product, testing category, animal, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Consumables, Reagents & Kits
• Equipment & Instruments
• Animal Outlook (Revenue, USD Million, 2021 - 2033)
• Companion Animals
  • Dogs
  • Cats
  • Horses
  • Other Companion Animals
• Production Animals
  • Cattle
  • Poultry
  • Swine
  • Other Production Animals
• Testing Category Outlook (Revenue, USD Million, 2021 - 2033)
• Clinical Chemistry
• Microbiology
• Parasitology
• Histopathology
• Cytopathology
• Hematology
• Immunology & Serology
• Imaging
• Molecular Diagnostics
• Other Categories
• Veterinary Diagnostics Market by End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Reference Laboratories
• Veterinarians
• Animal Owners/ Producers
• Veterinary Diagnostics Market by Region Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • UAE
  • Saudi Arabia
  • Kuwait
  • Qatar
  • Oman

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Testing Category
  • 1.2.3. Animal
  • 1.2.4. End Use
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information/Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Model 1: Commodity Flow Analysis
  • 1.7.2. Model 2: Bottom Up Analysis
  • 1.7.3. Model 3: Multivariate Analysis
• 1.8. List of Secondary Sources
• 1.9. List Of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary/Related Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing Pet Ownership & Rising Animal Health Awareness
    • 3.2.1.2. Rising Prevalence of Chronic & Infectious Diseases in Animals
    • 3.2.1.3. Growing Demand for Animal Derived Products.
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Shortage of Skilled Professionals
    • 3.2.2.2. Limited Infrastructure in Rural & Developing Regions
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Technology Landscape
• 3.4. Pricing Analysis
• 3.5. Estimated Animal Population, By Key Species, Key Countries, 2025
• 3.6. Disease Prevalence Analysis, 2025
• 3.7. Market Analysis Tools
  • 3.7.1. Porter's Five Forces Analysis
  • 3.7.2. PESTEL by SWOT Analysis

Chapter 4. Veterinary Diagnostics Market: Product Estimates & Trend Analysis

• 4.1. Veterinary Diagnostics Market, By Product: Segment Dashboard
• 4.2. Veterinary Diagnostics Market, By Product Movement Analysis
• 4.3. Veterinary Diagnostics Market Estimates & Forecasts, by Product, 2021 to 2033 (USD Million)
• 4.4. Consumables, Reagents & Kits
  • 4.4.1. Consumables, Reagents & Kits Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 4.5. Equipment & Instruments
  • 4.5.1. Equipment & Instruments Market Estimates and Forecasts, 2021 - 2033(USD Million)

Chapter 5. Veterinary Diagnostics Market: By Testing Category Estimates & Trend Analysis

• 5.1. Veterinary Diagnostics Market, By Testing Category: Segment Dashboard
• 5.2. Veterinary Diagnostics Market, By Testing Category Movement Analysis
• 5.3. Veterinary Diagnostics Market Estimates & Forecasts, by Testing Category, 2021 to 2033 (USD Million)
• 5.4. Clinical Chemistry
  • 5.4.1. Clinical Chemistry Market Estimates and Forecasts, 2021 - 2033(USD Million)
• 5.5. Microbiology
  • 5.5.1. Microbiology Market Estimates and Forecasts, 2021 - 2033(USD Million)
• 5.6. Parasitology
  • 5.6.1. Parasitology Market Estimates and Forecasts, 2021 - 2033(USD Million)
• 5.7. Histopathology
  • 5.7.1. Histopathology Market Estimates and Forecasts, 2021 - 2033(USD Million)
• 5.8. Cytopathology
  • 5.8.1. Cytopathology Market Estimates and Forecasts, 2021 - 2033(USD Million)
• 5.9. Hematology
  • 5.9.1. Hematology Market Estimates and Forecasts, 2021 - 2033(USD Million)
• 5.10. Immunology & Serology
  • 5.10.1. Immunology & Serology Market Estimates and Forecasts, 2021 - 2033(USD Million)
• 5.11. Imaging
  • 5.11.1. Imaging Market Estimates and Forecasts, 2021 - 2033(USD Million)
• 5.12. Molecular Diagnostics
  • 5.12.1. Molecular Diagnostics Market Estimates and Forecasts, 2021 - 2033(USD Million)
• 5.13. Other Categories
  • 5.13.1. Other Categories Market Estimates and Forecasts, 2021 - 2033(USD Million)

Chapter 6. Veterinary Diagnostics Market: By Animal Estimates & Trend Analysis

• 6.1. Veterinary Diagnostics Market, By Animal: Segment Dashboard
• 6.2. Veterinary Diagnostics Market, By Animal Movement Analysis
• 6.3. Veterinary Diagnostics Market Estimates & Forecasts, by Animal, 2021 to 2033 (USD Million)
• 6.4. Companion Animals
  • 6.4.1. Companion Animals Market Estimates and Forecasts, 2021 - 2033(USD Million)
  • 6.4.2. Dogs
    • 6.4.2.1. Dogs Market Estimates and Forecasts, 2021 - 2033(USD Million)
  • 6.4.3. Cats
    • 6.4.3.1. Cats Market Estimates and Forecasts, 2021 - 2033(USD Million)
  • 6.4.4. Horses
    • 6.4.4.1. Horses Market Estimates and Forecasts, 2021 - 2033(USD Million)
  • 6.4.5. Other Companion Animals
    • 6.4.5.1. Other Companion Animals Market Estimates and Forecasts, 2021 - 2033(USD Million)
• 6.5. Production Animals
  • 6.5.1. Production Animals Market Estimates and Forecasts, 2021 - 2033(USD Million)
  • 6.5.2. Cattle
    • 6.5.2.1. Cattle Market Estimates and Forecasts, 2021 - 2033(USD Million)
  • 6.5.3. Poultry
    • 6.5.3.1. Poultry Market Estimates and Forecasts, 2021 - 2033(USD Million)
  • 6.5.4. Swine
    • 6.5.4.1. Swine Market Estimates and Forecasts, 2021 - 2033(USD Million)
  • 6.5.5. Other Production Animals
    • 6.5.5.1. Other Production Animals Market Estimates and Forecasts, 2021 - 2033(USD Million)

Chapter 7. Veterinary Diagnostics Market: By End Use Estimates & Trend Analysis

• 7.1. Veterinary Diagnostics Market, By End Use: Segment Dashboard
• 7.2. Veterinary Diagnostics Market, By End Use Movement Analysis
• 7.3. Veterinary Diagnostics Market Estimates & Forecasts, by End Use, 2021 to 2033 (USD Million)
• 7.4. Reference Laboratories
  • 7.4.1. Reference Laboratories Market Estimates and Forecasts, 2021 - 2033(USD Million)
• 7.5. Veterinarians
  • 7.5.1. Veterinarians Market Estimates and Forecasts, 2021 - 2033(USD Million)
• 7.6. Animal Owners/Producers
  • 7.6.1. Animal Owners/Producers Market Estimates and Forecasts, 2021 - 2033(USD Million)

Chapter 8. Veterinary Diagnostics Market: By Regional Estimates & Trend Analysis

• 8.1. Region Market Dashboard
• 8.2. Region Market Share Analysis, 2025 & 2033
• 8.3. North America
  • 8.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.2. U.S
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Scenario
    • 8.3.2.3. Regulatory Framework
    • 8.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Scenario
    • 8.3.3.3. Regulatory Framework
    • 8.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Competitive Scenario
    • 8.3.4.3. Regulatory Framework
    • 8.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.2. UK
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Scenario
    • 8.4.5.3. Regulatory Framework
    • 8.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Scenario
    • 8.4.6.3. Regulatory Framework
    • 8.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.7. Denmark
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Scenario
    • 8.4.7.3. Regulatory Framework
    • 8.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.8. Sweden
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Competitive Scenario
    • 8.4.8.3. Regulatory Framework
    • 8.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Competitive Scenario
    • 8.4.9.3. Regulatory Framework
    • 8.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.2. Japan
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.5. Australia
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5.7. South Korea
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.7. MEA
  • 8.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.3. UAE
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.4. Saudi Arabia
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Framework
    • 8.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Framework
    • 8.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.6. Qatar
    • 8.7.6.1. Key Country Dynamics
    • 8.7.6.2. Competitive Scenario
    • 8.7.6.3. Regulatory Framework
    • 8.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7.7. Oman
    • 8.7.7.1. Key Country Dynamics
    • 8.7.7.2. Competitive Scenario
    • 8.7.7.3. Regulatory Framework
    • 8.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
  • 9.1.1. Market Leaders
  • 9.1.2. Emerging Players
• 9.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
• 9.3. Company Profiles
  • 9.3.1. IDEXX Laboratories, Inc.
    • 9.3.1.1. Participant's Overview
    • 9.3.1.2. Financial Performance
    • 9.3.1.3. Product Benchmarking
    • 9.3.1.4. Strategic Initiatives
  • 9.3.2. Zoetis
    • 9.3.2.1. Participant's Overview
    • 9.3.2.2. Financial Performance
    • 9.3.2.3. Product Benchmarking
    • 9.3.2.4. Strategic Initiatives
  • 9.3.3. Antech Diagnostics, Inc. (Mars Inc.).
    • 9.3.3.1. Participant's Overview
    • 9.3.3.2. Financial Performance
    • 9.3.3.3. Product Benchmarking
    • 9.3.3.4. Strategic Initiatives
  • 9.3.4. Agrolabo S.p.A.
    • 9.3.4.1. Participant's Overview
    • 9.3.4.2. Financial Performance
    • 9.3.4.3. Product Benchmarking
    • 9.3.4.4. Strategic Initiatives
  • 9.3.5. Embark Veterinary, Inc.
    • 9.3.5.1. Participant's Overview
    • 9.3.5.2. Financial Performance
    • 9.3.5.3. Product Benchmarking
    • 9.3.5.4. Strategic Initiatives
  • 9.3.6. Esaote SPA
    • 9.3.6.1. Participant's Overview
    • 9.3.6.2. Financial Performance
    • 9.3.6.3. Product Benchmarking
    • 9.3.6.4. Strategic Initiatives
  • 9.3.7. Thermo Fisher Scientific, Inc.
    • 9.3.7.1. Participant's Overview
    • 9.3.7.2. Financial Performance
    • 9.3.7.3. Product Benchmarking
    • 9.3.7.4. Strategic Initiatives
  • 9.3.8. Innovative Diagnostics SAS
    • 9.3.8.1. Participant's Overview
    • 9.3.8.2. Financial Performance
    • 9.3.8.3. Product Benchmarking
    • 9.3.8.4. Strategic Initiatives
  • 9.3.9. Virbac
    • 9.3.9.1. Participant's Overview
    • 9.3.9.2. Financial Performance
    • 9.3.9.3. Product Benchmarking
    • 9.3.9.4. Strategic Initiatives
  • 9.3.10. FUJIFILM Corporation
    • 9.3.10.1. Participant's Overview
    • 9.3.10.2. Financial Performance
    • 9.3.10.3. Product Benchmarking
    • 9.3.10.4. Strategic Initiatives